{"drugs":["Kinevac","Sincalide"],"mono":{"0":{"id":"549590-s-0","title":"Generic Names","mono":"Sincalide"},"1":{"id":"549590-s-1","title":"Dosing and Indications","sub":{"0":{"id":"549590-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Bowel imaging; Adjunct:<\/b> 0.04 mcg\/kg IV over 30 to 60 seconds administered after the barium meal is beyond the proximal jejunum; if satisfactory transit does not occur in 30 minutes, may give additional dose of 0.04 mcg\/kg IV; may also be administered as 30-minute IV infusion<\/li><li><b>Disorder of gallbladder; Diagnosis:<\/b> 0.02 mcg\/kg IV over 30 to 60 seconds; if contraction does not occur in 15 minutes, may give additional dose of 0.04 mcg\/kg IV; may also be administered IM at 0.1 mcg\/kg<\/li><li><b>Disorder of pancreas; Diagnosis:<\/b> initiate sincalide 0.02 mcg\/kg IV over 30 min, starting 30 min after the initiation of secretin 0.25 units\/kg IV over 60 min<\/li><\/ul>"},"3":{"id":"549590-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Bowel imaging; Adjunct<\/li><li>Disorder of gallbladder; Diagnosis<\/li><li>Disorder of pancreas; Diagnosis<\/li><\/ul>"}}},"3":{"id":"549590-s-3","title":"Contraindications\/Warnings","sub":[{"id":"549590-s-3-9","title":"Contraindications","mono":"<ul><li>hypersensitivity to sincalide products<\/li><li>intestinal obstruction<\/li><\/ul>"},{"id":"549590-s-3-10","title":"Precautions","mono":"small gallbladder stones, if present, may be evacuated and become lodged in the cystic duct or common bile duct <br\/>"},{"id":"549590-s-3-11","title":"Pregnancy Category","mono":"B (FDA)<br\/>"},{"id":"549590-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"549590-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Abdominal pain, Defecation urgency, Nausea<\/li><li><b>Musculoskeletal:<\/b>Cramp<\/li><li><b>Neurologic:<\/b>Dizziness, Headache<\/li><\/ul>"},"6":{"id":"549590-s-6","title":"Drug Name Info","sub":{"0":{"id":"549590-s-6-17","title":"US Trade Names","mono":"Kinevac<br\/>"},"2":{"id":"549590-s-6-19","title":"Class","mono":"Diagnostic Agent<br\/>"},"3":{"id":"549590-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"549590-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"7":{"id":"549590-s-7","title":"Mechanism Of Action","mono":"<ul><li>Systemic: Sincalide, a synthetically-prepared C-terminal octapeptide of the natural hormone cholecystokinin, induces contraction of the gallbladder muscle, resulting in reduction of gallbladder size and evacuation of bile. Also, sincalide, like cholecystokinin, stimulates secretion of pancreatic enzymes.<\/li><li>Sincalide decreases intestinal transit time; delays gastric emptying; decreases esophageal sphincter tone; inhibits gastric secretions; and stimulates intestinal muscle.<\/li><\/ul>"},"9":{"id":"549590-s-9","title":"Administration","mono":"<b>Intravenous<\/b><br\/><ul><li>inject slowly over 30-60 seconds<\/li><li>(infusion) may mix in 100 mL NS and give at a rate of 2 mL per minute, or may mix with 30 mL NS  and infuse over 30 minutes; use within 1 h of dilution<\/li><\/ul>"},"10":{"id":"549590-s-10","title":"Monitoring","mono":"<ul><li>abdominal pain<\/li><li>blood pressure during administration<\/li><\/ul>"},"11":{"id":"549590-s-11","title":"How Supplied","mono":"<b>Kinevac<\/b><br\/>Intravenous Powder for Solution: 5 MCG<br\/>"},"13":{"id":"549590-s-13","title":"Clinical Teaching","mono":"This drug may cause abdominal pain, defecation urgency, nausea, cramp, dizziness, or headache.<br\/>"}}}